Lennar Corporation (LEN) Stock Price Today
Aura AI Summary
Key Stats
- $20.47BMarket Cap
- 3,788,060Volume
- Consumer CyclicalSector
- $133.1352W High
- $73.5352W Low
- 69 DaysTypical Hold Time
- $24.89BEnterprise Value
- 2.32%Div Yield
- 99% Sell | 1% BuyTrading Activity
Track Lennar Corporation (LEN) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Lennar Corporation has traded between a low of $73.53 and a high of $133.13, highlighting its annual price range. Buy and sell Lennar Corporation shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Lennar Corporation
Lennar is the second-largest public homebuilder in the United States. The company's homebuilding operations target first-time, move-up, and active adult homebuyers mainly under the Lennar brand name. Lennar's financial-services segment provides mortgage financing and related services to its homebuyers. Miami-based Lennar is also involved in multifamily construction and has invested in numerous housing-related technology startups.
Most Recent News
Existing-home sales fell 5.5% in October, hitting lowest levels since 2010 amid rising mortgage rates.
Existing-home sales in the U.S. dropped 5.5% month-over-month and 8.8% year-over-year in October, reaching the lowest level since August 2010. The decline is attributed to mortgage rates rising to their highest since 2000, making home buying more dif...

atQor named finalist for 2026 Microsoft Partner of the Year for agentic AI solutions across industries
atQor has been named a finalist for the 2026 Microsoft Partner of the Year Award in the Agents category, recognized for its innovative and scalable agentic AI solutions deployed across nine industries. The company developed 252 AI agents in FY26, wit...

Global cell lysis and fractionation market to reach $4.5B by 2032, driven by biotech advances and personalized medicine.
The global cell lysis and cell fractionation market, valued at $2.8 billion in 2025, is projected to grow to $4.5 billion by 2032 at a 7% CAGR. Growth is fueled by advances in biotechnology, increased life sciences research investments, and rising de...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.